Helios deficiency has minimal impact on T cell development and function

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2303-2311

  Cai, Qi ^a,b   Dierich, Andrée ^a,b   Oulad Abdelghani, Mustapha ^a,b   Chan, Susan ^a,b   Kastner, Philippe ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOS PROTEIN; IKAROS TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; IKZF1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTION FACTOR; ZFPN1A1 PROTEIN, MOUSE; ZFPN1A2 PROTEIN, MOUSE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; FLOW CYTOMETRY; HOMOLOGOUS RECOMBINATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL CULTURE; CYTOLOGY; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MULTIGENE FAMILY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CLONE CELLS; DNA-BINDING PROTEINS; GENE SILENCING; IKAROS TRANSCRIPTION FACTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIGENE FAMILY; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 70149084214     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901407     Document Type: Article

References (45)

1. Cobb, B. S., and S. T. Smale. 2005. Ikaros-family proteins: in search of molecular functions during lymphocyte development. Curr. Top. Microbiol. Immunol. 290: 29-47.
2. Molnar, A., and K. Georgopoulos. 1994. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell Biol. 14: 8292-8303. (Pubitemid 24373578)
3. Hahm, K., P. Ernst, K. Lo, G. S. Kim, C. Turck, and S. T. Smale. 1994. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol. Cell. Biol. 14: 7111-7123. (Pubitemid 24326375)
4. Sun, L., A. Liu, and K. Georgopoulos. 1996. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15: 5358-5369. (Pubitemid 26336218)
5. Hahm, K., B. S. Cobb, A. S. McCarty, K. E. Brown, C. A. Klug, R. Lee, K. Akashi, I. L. Weissman, A. G. Fisher, and S. T. Smale. 1998. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev. 12: 782-796.
6. Morgan, B., L. Sun, N. Avitahl, K. Andrikopoulos, T. Ikeda, E. Gonzales, P. Wu, S. Neben, and K. Georgopoulos. 1997. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16: 2004-2013.
7. Perdomo, J., M. Holmes, B. Chong, and M. Crossley. 2000. Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. J. Biol. Chem. 275: 38347-38354.
8. McCarty, A. S., G. Kleiger, D. Eisenberg, and S. T. Smale. 2003. Selective dimerization of a C2H2 zinc finger subfamily. Mol. Cell 11: 459-470.
9. Kim, J., S. Sif, B. Jones, A. Jackson, J. Koipally, E. Heller, S. Winandy, A. Viel, A. Sawyer, T. Ikeda, et al. 1999. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345-355.
10. Sridharan, R., and S. T. Smale. 2007. Predominant Interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. J. Biol. Chem. 282: 30227-30238.
11. Nichogiannopoulou, A., M. Trevisan, S. Neben, C. Friedrich, and K. Georgopoulos. 1999. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190: 1201-1214.
12. Lopez, R. A., S. Schoetz, K. DeAngelis, D. O'Neill, and A. Bank. 2002. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc. Natl. Acad. Sci. USA 99: 602-607.
13. Allman, D., M. Dalod, C. Asselin-Paturel, T. Delale, S. H. Robbins, G. Trinchieri, C. A. Biron, P. Kastner, and S. Chan. 2006. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 108: 4025-4034. (Pubitemid 44913271)
14. Wang, J. H., A. Nichogiannopoulou, L. Wu, L. Sun, A. H. Sharpe, M. Bigby, and K. Georgopoulos. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
15. Wang, J. H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B. A. Morgan, and K. Georgopoulos. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity 9: 543-553.
16. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14: 603-615.
17. Cortes, M., and K. Georgopoulos. 2004. Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity. J. Exp. Med. 199: 209-219.
18. Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan. 2002. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32: 720-730. (Pubitemid 34257550)
19. Reynaud, D., I. A. Demarco, K. L. Reddy, H. Schjerven, E. Bertolino, Z. Chen, S. Smale, S. Winandy, and H. Singh. 2008. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9: 927-936.
20. Thompson, E. C., B. S. Cobb, P. Sabbattini, S. Meixlsperger, V. Parelho, D. Liberg, B. Taylor, N. Dillon, K. Georgopoulos, H. Jumaa, et al. 2007. Ikaros DNA-binding proteins as integral components of B cell developmental-stage- specific regulatory circuits. Immunity 26: 335-344.
21. Sellars, M., B. Reina-San-Martin, P. Kastner, and S. Chan. 2009. Ikaros controls isotype selection during immunoglobulin class switch recombination. J. Exp. Med. 206: 1073-1087.
22. Winandy, S., L. Wu, J. H. Wang, and K. Georgopoulos. 1999. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190: 1039-1048.
23. Urban, J. A., and S. Winandy. 2004. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions. J. Immunol. 173: 4470-4478.
24. Urban, J. A., W. Brugmann, and S. Winandy. 2009. Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: a study using CD3ζ immunoreceptor tyrosine-based activation motif transgenic mice. J. Immunol. 182: 3955-3959.
25. Quirion, M. R., G. D. Gregory, S. E. Umetsu, S. Winandy, and M. A. Brown. 2009. Cutting edge: Ikaros is a regulator of Th2 cell differentiation. J. Immunol. 182: 741-745.
26. Avitahl, N., S. Winandy, C. Friedrich, B. Jones, Y. Ge, and K. Georgopoulos. 1999. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 333-343. (Pubitemid 29165288)
27. Kleinmann, E., A. S. Geimer Le Lay, M. Sellars, P. Kastner, and S. Chan. 2009. Ikaros represses the transcriptional response to Notch signaling in T-cell development. Mol. Cell. Biol. 28: 7465-7475.
28. Winandy, S., P. Wu, and K. Georgopoulos. 1995. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
29. Dumortier, A., R. Jeannet, P. Kirstetter, E. Kleinmann, M. Sellars, N. R. Dos Santos, C. Thibault, J. Barths, J. Ghysdael, J. A. Punt, et al. 2006. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell. Biol. 26: 209-220.
30. Kelley, C. M., T. Ikeda, J. Koipally, N. Avitahl, L. Wu, K. Georgopoulos, and B. A. Morgan. 1998. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8: 508-515.
31. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
32. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18: 1197-1209.
33. Hill, J. A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and C. Benoist. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800.
34. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462.
35. Zhang, Z., C. S. Swindle, J. T. Bates, R. Ko, C. V. Cotta, and C. A. Klug. 2007. Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood 109: 2190-2197.
36. Nakase, K., F. Ishimaru, K. Fujii, T. Tabayashi, T. Kozuka, N. Sezaki, Y. Matsuo, and M. Harada. 2002. Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia. Exp. Hematol. 30: 313-317.
37. Fujii, K., F. Ishimaru, K. Nakase, T. Tabayashi, T. Kozuka, K. Naoki, M. Miyahara, H. Toki, K. Kitajima, M. Harada, and M. Tanimoto. 2003. Overexpression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br. J. Haematol. 120: 986-989.
38. Tabayashi, T., F. Ishimaru, M. Takata, I. Kataoka, K. Nakase, T. Kozuka, and M. Tanimoto. 2007. Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies. Cancer Sci. 98: 182-188.
39. Fujiwara, S. I., Y. Yamashita, N. Nakamura, Y. L. Choi, T. Ueno, H. Watanabe, K. Kurashina, M. Soda, M. Enomoto, H. Hatanaka, et al. 2008. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays. Leukemia 22: 1891-1898.
40. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19: 2499.
41. Tu, L., T. C. Fang, D. Artis, O. Shestova, S. E. Pross, I. Maillard, and W. S. Pear. 2005. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202: 1037-1042.
42. Elliott, J., C. Jolicoeur, V. Ramamurthy, and M. Cayouette. 2008. Ikaros confers early temporal competence to mouse retinal progenitor cells. Neuron 60: 26-39.
43. Ezzat, S., and S. L. Asa. 2008. The emerging role of the Ikaros stem cell factor in the neuroendocrine system. J. Mol. Endocrinol. 41: 45-51.
44. Kiehl, T. R., S. E. Fischer, S. Ezzat, and S. L. Asa. 2008. Mice lacking the transcription factor Ikaros display behavioral alterations of an anti-depressive phenotype. Exp. Neurol. 211: 107-114.
45. Chatila, T. 2007. The regulatory T cell transcriptosome: E pluribus unum. Immunity 27: 693-695. (Pubitemid 350102264)